Linden Thomas Advisory Services LLC Sells 363 Shares of Solventum Co. (NYSE:SOLV)

Linden Thomas Advisory Services LLC lessened its stake in Solventum Co. (NYSE:SOLV) by 0.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 60,096 shares of the company’s stock after selling 363 shares during the quarter. Linden Thomas Advisory Services LLC’s holdings in Solventum were worth $3,970,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Modus Advisors LLC bought a new position in Solventum in the 4th quarter worth approximately $25,000. Copeland Capital Management LLC acquired a new stake in shares of Solventum in the 3rd quarter valued at $26,000. Mather Group LLC. acquired a new stake in shares of Solventum in the 3rd quarter valued at $27,000. Twin Lakes Capital Management LLC bought a new stake in shares of Solventum during the second quarter worth $29,000. Finally, True Wealth Design LLC lifted its stake in shares of Solventum by 23,550.0% during the third quarter. True Wealth Design LLC now owns 473 shares of the company’s stock valued at $33,000 after acquiring an additional 471 shares during the period.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. Mizuho assumed coverage on Solventum in a report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price objective for the company. Stifel Nicolaus started coverage on shares of Solventum in a research note on Tuesday, October 8th. They set a “buy” rating and a $82.00 price target for the company. Piper Sandler increased their price objective on shares of Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a report on Friday, November 8th. Finally, Morgan Stanley lifted their target price on shares of Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a report on Monday, November 11th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $68.29.

Solventum Stock Performance

Shares of NYSE:SOLV opened at $74.93 on Friday. The company has a 50 day moving average price of $69.56 and a two-hundred day moving average price of $66.30. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. Solventum Co. has a 52 week low of $47.16 and a 52 week high of $96.05.

Solventum (NYSE:SOLV) last released its quarterly earnings data on Thursday, November 7th. The company reported $1.15 EPS for the quarter, missing analysts’ consensus estimates of $1.38 by ($0.23). The company had revenue of $2.08 billion for the quarter, compared to analyst estimates of $2.05 billion. As a group, analysts forecast that Solventum Co. will post 6.58 EPS for the current year.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.